| Dr Rosalie C Keith, DO | |
|
100 W University St, Alfred, NY 14802-1134 | |
| (607) 587-9208 | |
| (607) 587-9208 |
| Full Name | Dr Rosalie C Keith |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 39 Years |
| Location | 100 W University St, Alfred, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851386742 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 171396 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Griffiss Ec, Llc | 8628249521 | 14 |
News Archive
NYU Langone Medical Center will launch a new institutional advertising campaign based on real stories from the Medical Center beginning on October 5, 2009. The campaign, "Any Given Moment," captures and conveys some of the most powerful, intimate and uniquely human experiences to emerge from the Medical Center and features the Medical Center's core clinical care and research strengths.
Protecting infants from viral infections may prevent the development of asthma late in childhood, according to new research in the Journal of Allergy and Clinical Immunology (JACI).
Patients with schizophrenia who have contemplated suicide or made one suicide attempt have better cognitive functioning than those who have not, research shows.
Emergent BioSolutions Inc. announced that a joint delegation of Members of the European Parliament and representatives from the Oxford-Emergent Tuberculosis Consortium today visited the trial site where MVA85A, the world's most clinically advanced tuberculosis vaccine candidate in development, is being studied in a Phase IIb infant efficacy clinical trial.
› Verified 2 days ago
| Entity Name | American Anesthesiology Of New York, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114973724 PECOS PAC ID: 9537050968 Enrollment ID: O20040323001912 |
News Archive
NYU Langone Medical Center will launch a new institutional advertising campaign based on real stories from the Medical Center beginning on October 5, 2009. The campaign, "Any Given Moment," captures and conveys some of the most powerful, intimate and uniquely human experiences to emerge from the Medical Center and features the Medical Center's core clinical care and research strengths.
Protecting infants from viral infections may prevent the development of asthma late in childhood, according to new research in the Journal of Allergy and Clinical Immunology (JACI).
Patients with schizophrenia who have contemplated suicide or made one suicide attempt have better cognitive functioning than those who have not, research shows.
Emergent BioSolutions Inc. announced that a joint delegation of Members of the European Parliament and representatives from the Oxford-Emergent Tuberculosis Consortium today visited the trial site where MVA85A, the world's most clinically advanced tuberculosis vaccine candidate in development, is being studied in a Phase IIb infant efficacy clinical trial.
› Verified 2 days ago
| Entity Name | Premier Anesthesia Of New York, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063658961 PECOS PAC ID: 7719041102 Enrollment ID: O20090129000560 |
News Archive
NYU Langone Medical Center will launch a new institutional advertising campaign based on real stories from the Medical Center beginning on October 5, 2009. The campaign, "Any Given Moment," captures and conveys some of the most powerful, intimate and uniquely human experiences to emerge from the Medical Center and features the Medical Center's core clinical care and research strengths.
Protecting infants from viral infections may prevent the development of asthma late in childhood, according to new research in the Journal of Allergy and Clinical Immunology (JACI).
Patients with schizophrenia who have contemplated suicide or made one suicide attempt have better cognitive functioning than those who have not, research shows.
Emergent BioSolutions Inc. announced that a joint delegation of Members of the European Parliament and representatives from the Oxford-Emergent Tuberculosis Consortium today visited the trial site where MVA85A, the world's most clinically advanced tuberculosis vaccine candidate in development, is being studied in a Phase IIb infant efficacy clinical trial.
› Verified 2 days ago
| Entity Name | Wyoming Urgent Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821492935 PECOS PAC ID: 2567786973 Enrollment ID: O20150113000675 |
News Archive
NYU Langone Medical Center will launch a new institutional advertising campaign based on real stories from the Medical Center beginning on October 5, 2009. The campaign, "Any Given Moment," captures and conveys some of the most powerful, intimate and uniquely human experiences to emerge from the Medical Center and features the Medical Center's core clinical care and research strengths.
Protecting infants from viral infections may prevent the development of asthma late in childhood, according to new research in the Journal of Allergy and Clinical Immunology (JACI).
Patients with schizophrenia who have contemplated suicide or made one suicide attempt have better cognitive functioning than those who have not, research shows.
Emergent BioSolutions Inc. announced that a joint delegation of Members of the European Parliament and representatives from the Oxford-Emergent Tuberculosis Consortium today visited the trial site where MVA85A, the world's most clinically advanced tuberculosis vaccine candidate in development, is being studied in a Phase IIb infant efficacy clinical trial.
› Verified 2 days ago
| Entity Name | Griffiss Ec, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487259545 PECOS PAC ID: 8628249521 Enrollment ID: O20210129000536 |
News Archive
NYU Langone Medical Center will launch a new institutional advertising campaign based on real stories from the Medical Center beginning on October 5, 2009. The campaign, "Any Given Moment," captures and conveys some of the most powerful, intimate and uniquely human experiences to emerge from the Medical Center and features the Medical Center's core clinical care and research strengths.
Protecting infants from viral infections may prevent the development of asthma late in childhood, according to new research in the Journal of Allergy and Clinical Immunology (JACI).
Patients with schizophrenia who have contemplated suicide or made one suicide attempt have better cognitive functioning than those who have not, research shows.
Emergent BioSolutions Inc. announced that a joint delegation of Members of the European Parliament and representatives from the Oxford-Emergent Tuberculosis Consortium today visited the trial site where MVA85A, the world's most clinically advanced tuberculosis vaccine candidate in development, is being studied in a Phase IIb infant efficacy clinical trial.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rosalie C Keith, DO 100 W University St, Alfred, NY 14802-1134 Ph: (607) 587-9208 | Dr Rosalie C Keith, DO 100 W University St, Alfred, NY 14802-1134 Ph: (607) 587-9208 |
News Archive
NYU Langone Medical Center will launch a new institutional advertising campaign based on real stories from the Medical Center beginning on October 5, 2009. The campaign, "Any Given Moment," captures and conveys some of the most powerful, intimate and uniquely human experiences to emerge from the Medical Center and features the Medical Center's core clinical care and research strengths.
Protecting infants from viral infections may prevent the development of asthma late in childhood, according to new research in the Journal of Allergy and Clinical Immunology (JACI).
Patients with schizophrenia who have contemplated suicide or made one suicide attempt have better cognitive functioning than those who have not, research shows.
Emergent BioSolutions Inc. announced that a joint delegation of Members of the European Parliament and representatives from the Oxford-Emergent Tuberculosis Consortium today visited the trial site where MVA85A, the world's most clinically advanced tuberculosis vaccine candidate in development, is being studied in a Phase IIb infant efficacy clinical trial.
› Verified 2 days ago